1 World Economic Forum. Gobal Risks 2013. Eighth Edition. 2013.
2 O’Neil J. Antimicrobial Resistance: Tackling a Crisis for the Health and Wealth of Nations. O’Neill Report Wellcome Trust. Review on Antimicrobial Resistance. 2014.
3 Walsh TR. A one-health approach to antimicrobial resistance. Nat Microbiol. 2018;3:854–5.
4 Bundesamt für Gesundheit. Bevölkerungsumfrage zu Antibiotikaresistenzen. Schlussbericht 2018. 2018.
5 Tacconelli E, Cataldo MA, Dancer SJ, et al. ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients. Clin Microbiol Infect 2014;20 Suppl. 1:1–55.
6 Remschmidt C, Behnke M, Kola A, et al. The effect of antibiotic use on prevalence of nosocomial vancomycin-resistant enterococci- an ecologic study. Antimicrob Resist Infect Control. 2017;6:95.
7 David S, Reuter S, Harris SR, et al. Epidemic of carbapenem-resistant Klebsiella pneumoniae in Europe is driven by nosocomial spread. Nat Microbiol. 2019;4:1919–29.
8 Di Ruscio F, Guzzetta G, Bjornholt JV, et al. Quantifying the transmission dynamics of MRSA in the community and healthcare settings in a low-prevalence country. Proc Natl Acad Sci U S A. 2019;116:14599–605.
9 Jain S, Clezy K, McLaws ML. Safe removal of gloves from contact precautions: The role of hand hygiene. Am J Infect Control. 2018;46:764–7.
10 Martischang R, Riccio ME, Abbas M, Stewardson AJ, Kluytmans J, Harbarth S. Household carriage and acquisition of extended-spectrum beta-lactamase-producing Enterobacteriaceae: A systematic review. Infect Control Hosp Epidemiol. 2020;41:286–94.
11 Burki T. England and Wales see 20 000 excess deaths in care homes. Lancet. 2020;395:1602.
12 Team EPHE, Danis K, Fonteneau L, et al. High impact of COVID-19 in long-term care facilities, suggestion for monitoring in the EU/EEA, May 2020. Euro Surveill. 2020;25.
13 Fisman DN, Bogoch I, Lapointe-Shaw L, McCready J, Tuite AR. Risk Factors Associated With Mortality Among Residents With Coronavirus Disease 2019 (COVID-19) in Long-term Care Facilities in Ontario, Canada. JAMA Netw Open. 2020;3:e2015957.
14 Barnett ML, Grabowski DC. Nursing Homes Are Ground Zero for COVID-19 Pandemic. JAMA Health Forum. 2020;1:e200369-e.
15 Lee MH, Lee GA, Lee SH, Park YH. A systematic review on the causes of the transmission and control measures of outbreaks in long-term care facilities: Back to basics of infection control. PLoS One. 2020;15:e0229911.
16 Ben-David D, Masarwa S, Fallach N, et al. Success of a National Intervention in Controlling Carbapenem-resistant Enterobacteriaceae in Israel’s Long-term Care Facilities. Clin Infect Dis. 2019;68:964–71.
17 Gurtler N, Erba A, Giehl C, Tschudin-Sutter S, Bassetti S, Osthoff M. Appropriateness of antimicrobial prescribing in a Swiss tertiary care hospital: a repeated point prevalence survey. Swiss Med Wkly. 2019;149:w20135.
18 World Health Organization. Clinical management of COVID-19. 2020.
19 Marriott D, Beresford R, Mirdad F, et al. Concomitant marked decline in prevalence of SARS-CoV-2 and other respiratory viruses among symptomatic patients following public health interventions in Australia: data from St Vincent’s Hospital and associated screening clinics, Sydney, NSW. Clin Infect Dis. 2020. Aug 25;ciaa1256.
21 Arcilla MS, van Hattem JM, Haverkate MR, et al. Import and spread of extended-spectrum beta-lactamase-producing Enterobacteriaceae by international travellers (COMBAT study): a prospective, multicentre cohort study. Lancet Infect Dis. 2017;17:78–85.
22 Kuenzli E, Jaeger VK, Frei R, et al. High colonization rates of extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli in Swiss travellers to South Asia – a prospective observational multicentre cohort study looking at epidemiology, microbiology and risk factors. BMC Infect Dis. 2014;14:528.
23 Budd J, Miller BS, Manning EM, et al. Digital technologies in the public-health response to COVID-19. Nat Med. 2020;26:1183–92.